Relation of AURKB over-expression to low survival rate in BCRA and reversine-modulated aurora B kinase in breast cancer cell lines
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relation of AURKB over-expression to low survival rate in BCRA and reversine-modulated aurora B kinase in breast cancer cell lines
Authors
Keywords
Reversine, BRCA, Triple-negative breast cancer cells, AURKB, Aurora B, microRNAs
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-18
DOI
10.1186/s12935-019-0885-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells
- (2018) Chiung-Yao Fang et al. ANTI-CANCER DRUGS
- Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy
- (2018) Li Cheng et al. OncoTargets and Therapy
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- TGF-β signaling in liver and gastrointestinal cancers
- (2016) L.H. Katz et al. CANCER LETTERS
- Ovine fetal mesenchymal stem cell differentiation to cardiomyocytes, effects of co-culture, role of small molecules; reversine and 5-azacytidine
- (2016) Leila Soltani et al. CELL BIOCHEMISTRY AND FUNCTION
- Reversine Increases the Plasticity of Long-Term Cryopreserved Fibroblasts to Multipotent Progenitor Cells through Activation of Oct4
- (2016) Xiangchen Li et al. International Journal of Biological Sciences
- Reversine triggers mitotic catastrophe and apoptosis in K562 cells
- (2016) Ana Paula Nunes Rodrigues Alves et al. LEUKEMIA RESEARCH
- Embelin Inhibits Invasion and Migration of MDA-MB-231 Breast Cancer Cells by Suppression of CXC Chemokine Receptor 4, Matrix Metalloproteinases-9/2, and Epithelial-Mesenchymal Transition
- (2016) Hanwool Lee et al. PHYTOTHERAPY RESEARCH
- Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer
- (2016) Haiyan Zhu et al. TUMOR BIOLOGY
- Novel signaling collaboration between TGF-β and adaptor protein Crk facilitates EMT in human lung cancer
- (2016) Aiman Z. Elmansuri et al. Oncotarget
- miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression
- (2016) Li-Kun Hou et al. Oncotarget
- Possibility of Breast Cancer Prevention: Use of Soy Isoflavones and Fermented Soy Beverage Produced Using Probiotics
- (2015) Akimitsu Takagi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer
- (2015) Yue Yu et al. Oncotarget
- PROGgeneV2: enhancements on the existing database
- (2015) Chirayu Pankaj Goswami et al. BMC CANCER
- Breast Cancer: Major Risk Factors and Recent Developments in Treatment
- (2014) Wafa Majeed et al. Asian Pacific Journal of Cancer Prevention
- Reversine increases the plasticity of lineage-committed preadipocytes to osteogenesis by inhibiting adipogenesis through induction of TGF-β pathway in vitro
- (2014) Jeong Geun Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Autophagy induction of reversine on human follicular thyroid cancer cells
- (2012) Chieh-Hsiang Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- Reversine promotes porcine muscle derived stem cells (PMDSCs) differentiation into female germ-like cells
- (2012) Xiao Lv et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells
- (2012) Chin-Ho Kuo et al. Breast Cancer
- MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2
- (2011) T. Shatseva et al. JOURNAL OF CELL SCIENCE
- Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine
- (2010) L Anastasia et al. CELL DEATH AND DIFFERENTIATION
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Breast cancer as a global health concern
- (2009) Steven S. Coughlin et al. Cancer Epidemiology
- Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
- (2009) G. Sotiropoulou et al. RNA
- Reversine Enhances Generation of Progenitor-like Cells by Dedifferentiation of Annulus Fibrosus Cells
- (2009) Mansi Saraiya et al. TISSUE ENGINEERING PART A
- The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts
- (2008) G Amabile et al. CELL DEATH AND DIFFERENTIATION
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Reversine Increases the Plasticity of Lineage-committed Cells toward Neuroectodermal Lineage
- (2008) Eun Kyung Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells
- (2008) A. M. D'Alise et al. MOLECULAR CANCER THERAPEUTICS
- Breast Cancer Issues in Developing Countries: An Overview of the Breast Health Global Initiative
- (2008) Benjamin O. Anderson et al. WORLD JOURNAL OF SURGERY
- Aurora kinases as targets for cancer therapy
- (2007) Giannis Mountzios et al. CANCER TREATMENT REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started